Jesús
Barreiro Conde
Universidade de Santiago de Compostela
Santiago de Compostela, EspañaPublications in collaboration with researchers from Universidade de Santiago de Compostela (22)
2017
-
Acantosis nigricans in severe insulin resistance syndromes
Anales de Pediatria, Vol. 86, Núm. 3, pp. 166-168
2011
-
Congenital hypothyroidism with neurological and respiratory alterations: A case detected using a variable diagnostic threshold for Tsh
JCRPE Journal of Clinical Research in Pediatric Endocrinology, Vol. 3, Núm. 4, pp. 208-211
-
Evolutionary analyses of entire genomes do not support the association of mtdna mutations with ras/mapk pathway syndromes
PLoS ONE, Vol. 6, Núm. 4
-
Genetic diagnosis of X-linked dominant hypophosphatemic rickets in a cohort study: Tubular reabsorption of phosphate and 1,25(OH)2D serum levels are associated with PHEX mutation type
BMC Medical Genetics, Vol. 12
-
Pituitary stalk dysgenesis-induced hypopituitarism in adult patients: Prevalence, evolution of hormone dysfunction and genetic analysis
Neuroendocrinology, Vol. 93, Núm. 3, pp. 181-188
2008
-
Hypochondroplasia and acanthosis nigricans: A new syndrome due to the p.Lys650Thr mutation in the fibroblast growth factor receptor 3 gene?
European Journal of Endocrinology, Vol. 159, Núm. 3, pp. 243-249
2007
-
Hipoglucemia neonatal
Anales de Pediatria
2006
-
High variability in CYP21A2 mutated alleles in Spanish 21-hydroxylase deficiency patients, six novel mutations and a founder effect
Clinical Endocrinology, Vol. 64, Núm. 3, pp. 330-336
2005
-
Genetic basis of short stature
Journal of Endocrinological Investigation
-
Kallmann's syndrome with a novel missense mutation in the KAL1 gene that modifies the major cell adhesion site of the anosmin-1 protein
Journal of Pediatric Endocrinology and Metabolism, Vol. 18, Núm. 6, pp. 545-548
-
Papillary thyroid carcinoma after recombinant GH therapy for Turner syndrome
European Journal of Endocrinology, Vol. 153, Núm. 4, pp. 499-502
2004
-
Therapeutic optimization of growth hormone deficiency in children and adolescents
Journal of Pediatric Endocrinology and Metabolism, Vol. 17, Núm. SUPPL. 3, pp. 401-410
-
Tratamiento combinado con análogos de GnRH y GH
Anales de Pediatria, Vol. 60, pp. 15-23
2003
-
Optimización terapéutica del déficit de hormona de crecimiento en niños y adolescentes
Anales de Pediatria, Vol. 58, Núm. SUPPL. 2, pp. 3-11
1999
-
High serum leptin levels in children with type 1 diabetes mellitus: Contribution of age, BMI, pubertal development and metabolic status
Clinical Endocrinology, Vol. 51, Núm. 5, pp. 603-610
1997
-
Crecimiento en patología oncológica
Anales Espanoles de Pediatria, Vol. 46, Núm. 2 SUPPL. 2, pp. 160-162
-
Nocturnal rise of leptin in normal prepubertal and pubertal children and in patients with perinatal stalk-transection syndrome
Journal of Clinical Endocrinology and Metabolism, Vol. 82, Núm. 8, pp. 2751-2754
1996
-
Growth hormone releasing hexapeptide-6 (GHRP-6) in test in the diagnosis of GH-deficiency
Journal of Pediatric Endocrinology and Metabolism
1995
-
Absence of growth hormone (GH) secretion after the administration of either GH-releasing hormone (GHRH), GH-releasing peptide (GHRP-6), or GHRH plus GHRP-6 in children with neonatal pituitary stalk transection
Journal of Clinical Endocrinology and Metabolism, Vol. 80, Núm. 11, pp. 3180-3184
-
Plasma growth hormone response to growth hormone‐releasing hexapeptide (GH‐RP‐6) in children with short stature
Acta Pædiatrica, Vol. 84, Núm. 8, pp. 904-908